home / stock / legn / legn quote
Last: | $58.74 |
---|---|
Change Percent: | 0.33% |
Open: | $58.05 |
Close: | $58.74 |
High: | $58.89 |
Low: | $56.63 |
Volume: | 961,069 |
Last Trade Date Time: | 07/19/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$58.74 | $58.05 | $58.74 | $58.89 | $56.63 | 961,069 | 07-19-2024 |
$58.24 | $54.97 | $58.24 | $60 | $54.715 | 1,453,797 | 07-18-2024 |
$55 | $55 | $55 | $56.8598 | $54.28 | 2,495,251 | 07-17-2024 |
$55.9 | $54.47 | $55.9 | $57.82 | $54.27 | 1,681,963 | 07-16-2024 |
$53.99 | $55.01 | $53.99 | $57.49 | $53.01 | 2,370,524 | 07-15-2024 |
$54.37 | $49.39 | $54.37 | $57.5 | $48.215 | 4,891,167 | 07-12-2024 |
$48.5 | $47.79 | $48.5 | $49.455 | $47.12 | 1,047,018 | 07-11-2024 |
$47.32 | $46.56 | $47.32 | $47.555 | $46.2 | 271,579 | 07-10-2024 |
$46.71 | $47.36 | $46.71 | $47.73 | $46.02 | 633,758 | 07-09-2024 |
$47.41 | $46.37 | $47.41 | $47.73 | $46.31 | 447,905 | 07-08-2024 |
$46.3 | $45.64 | $46.3 | $46.88 | $45.31 | 535,970 | 07-05-2024 |
$45.91 | $44.66 | $45.91 | $46.69 | $44.19 | 356,980 | 07-04-2024 |
$45.91 | $44.66 | $45.91 | $46.69 | $44.19 | 356,980 | 07-03-2024 |
$44.74 | $46.14 | $44.74 | $47.3856 | $44.57 | 908,357 | 07-02-2024 |
$46.02 | $44.63 | $46.02 | $46.49 | $44.505 | 1,556,321 | 07-01-2024 |
$44.29 | $44.76 | $44.29 | $44.7899 | $43.64 | 571,398 | 06-28-2024 |
$44.66 | $44.22 | $44.66 | $44.98 | $43.74 | 652,601 | 06-27-2024 |
$44.89 | $43.23 | $44.89 | $45.31 | $42.61 | 1,164,891 | 06-26-2024 |
$43.52 | $42.63 | $43.52 | $43.64 | $41.89 | 1,180,911 | 06-25-2024 |
$43.09 | $42.85 | $43.09 | $43.9 | $42.39 | 885,190 | 06-24-2024 |
News, Short Squeeze, Breakout and More Instantly...
Legend Biotech Corporation Company Name:
LEGN Stock Symbol:
NASDAQ Market:
Legend Biotech Corporation Website:
SOMERSET, N.J., July 10, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 am ET on Friday, August 9, 2024, to review second-quarter 2024 results. During the webcast and confe...
SOMERSET, N.J., July 02, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, announced today positive overall survival results from CARTITUDE-4, an ongoing, global randomized, open-label Phase 3 study evaluating the efficacy and sa...
2024-06-20 17:01:11 ET USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – June 20,2024 – USA News Group News Commentary – The potential threat of cancer looms for everyone, but now new studies are revealing an increased number o...